Abstract
AbstractCell-free DNA (cfDNA) is a rich source of biomarkers for various (patho)physiological conditions. Recent developments have used Machine Learning on large cfDNA data sets to enhance the detection of cancers and immunological diseases. Preanalytical variables, such as the library preparation protocol or sequencing platform, are major confounders that influence such data sets and lead to domain shifts (i.e., shifts in data distribution as those confounders vary across time or space). Here, we present a domain adaptation method that builds on the concept of optimal transport, and explicitly corrects for the effect of such preanalytical variables. Our approach can be used to merge cohorts representative of the same population but separated by technical biases. Moreover, we also demonstrate that it improves cancer detection via Machine Learning by alleviating the sources of variation that are not of biological origin. Our method also improves over the widely used GC-content bias correction, both in terms of bias removal and cancer signal isolation. These results open perspectives for the downstream analysis of larger data sets through the integration of cohorts produced by different sequencing pipelines or collected in different centers. Notably, the approach is rather general with the potential for application to many other genomic data analysis problems.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. Integration of Noninvasive DNA Testing for Aneuploidy into Prenatal Care: What Has Happened Since the Rubber Met the Road?
2. Dardour Leila , Nathalie Brison , Kris Van den Bogaert , Luc Dehaspe , Katrien Janssens , Bettina Blaumeiser , Sonia Van Dooren , Ann Van Den Bogaert , Kathelijn Keymolen , Julie Désir , et al. Incidence of uncommon fetal aneuploidies detected by non-invasive prenatal testing. In 17th annual Belgian Society of Human Genetics meeting: Human genetics goes somatic, pages 100–100. Belgian Society of Human Genetics, 2017.
3. Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection
4. Genomewide copy number alteration screening of circulating plasma dna: potential for the detection of incipient tumors;Annals of Oncology,2019
5. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.